RCM
TMO icon

RNC Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

RNC Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.93M Buy
13,815
+84
+0.6% +$40.3K 0.29% 49
2026
Q1 		$6.75M Buy
13,731
+582
+4% +$316K 0.3% 49
2025
Q4 		$7.62M Sell
13,149
-417
-3% -$236K 0.35% 47
2025
Q3 		$6.58M Buy
13,566
+77
+0.6% +$35.8K 0.3% 49
2025
Q2 		$5.47M Buy
13,489
+2,472
+22% +$1.03M 0.27% 51
2025
Q1 		$5.48M Buy
11,017
+1,237
+13% +$670K 0.28% 51
2024
Q4 		$5.09M Sell
9,780
-1,913
-16% -$1.05M 0.27% 52
2024
Q3 		$6.47M Hold
11,693
– – 0.36% 46
2024
Q2 		$6.47M Buy
11,693
+1,157
+11% +$663K 0.36% 46
2024
Q1 		$6.12M Buy
10,536
+2,200
+26% +$1.23M 0.35% 48
2023
Q4 		$4.42M Sell
8,336
-118
-1% -$57.1K 0.27% 52
2023
Q3 		$4.28M Buy
+8,454
New +$4.5M 0.27% 52

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RNC Capital Management's TMO Position: Q2 2026 in Review

RNC Capital Management increased its Thermo Fisher Scientific (TMO) stake by 0.61% in Q2 2026, buying an estimated $40.3K and bringing the position to 13,815 shares worth $6.93M. The position accounts for 0.29% of the portfolio, ranked #49.

RNC Capital Management first reported a position in TMO in Q3 2023 and has held it in 12 quarters since. The position peaked at $7.62M in Q4 2025. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • RNC Capital Management held 13,815 shares of Thermo Fisher Scientific worth $6.93M as of Q2 2026.
  • RNC Capital Management bought 84 Thermo Fisher Scientific shares in Q2 2026, an estimated $40.3K.
  • Thermo Fisher Scientific made up 0.29% of RNC Capital Management's portfolio in Q2 2026, its #49 holding.
  • RNC Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 12 quarters since.
  • RNC Capital Management's Thermo Fisher Scientific position peaked at $7.62M in Q4 2025.
  • 2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on RNC Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.